The L-coding region of the DA strain of theiler's murine encephalomyelitis virus causes dysfunction and death of myelin-synthesizing cells

Journal of Virology

Volumn 85, Issue 18, 2011, Pages 9377-9384

  Ghadge, G D ^a   Wollmann, R ^a   Baida, G ^a   Traka, M ^a,b   Roos, R P ^a,b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b The University of Chicago Pritzker School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DA VIRUS STRAIN; DEMYELINATING DISEASE; DEMYELINATION; DISEASE COURSE; GENE EXPRESSION; GENE LOCUS; GENE STRUCTURE; LYMPHOCYTIC INFILTRATION; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; MYELINATION; NONHUMAN; OLIGODENDROGLIA; PARALYSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHWANN CELL; TRANSGENE; VIRAL PHENOMENA AND FUNCTIONS; VIRUS STRAIN;

ANIMALS; CELL DEATH; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; MICE; MICE, TRANSGENIC; NEURONS; OLIGODENDROGLIA; POLIOMYELITIS; RNA, VIRAL; RODENT DISEASES; SCHWANN CELLS; THEILOVIRUS; VIRAL PROTEINS; VIRULENCE FACTORS;

MUS MUSCULUS; THEILER'S ENCEPHALOMYELITIS VIRUS; THEILER'S ENCEPHALOMYELITIS VIRUS (STRAIN DA);

EID: 80052446143     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00178-11     Document Type: Article

References (44)

1. Baida, G., et al. 2008. A subgenomic segment of Theiler's murine encephalomyelitis virus RNA causes demyelination. J. Virol. 82:5879-5886.
2. Brahic, M. 2010. Multiple sclerosis and viruses. Ann. Neurol. 68:6-8.
3. Buenz, E. J., et al. 2009. Apoptosis of hippocampal pyramidal neurons is virus independent in a mouse model of acute neurovirulent picornavirus infection. Am. J. Pathol. 175:668-684.
4. Carlson, N. G., K. E. Hill, I. Tsunoda, R. S. Fujinami, and J. W. Rose. 2006. The pathologic role for COX-2 in apoptotic oligodendrocytes in virus induced demyelinating disease: implications for multiple sclerosis. J. Neuroimmunol 174:21-31.
5. Chen, H. H., W. P. Kong, L. Zhang, P. L. Ward, and R. P. Roos. 1995. A picornaviral protein synthesized out of frame with the polyprotein plays a key role in a virus-induced immune-mediated demyelinating disease. Nat. Med. 1:927-931.
6. Delhaye, S., V. van Pesch, and T. Michiels. 2004. The leader protein of Theiler's virus interferes with nucleocytoplasmic trafficking of cellular proteins. J. Virol. 78:4357-4362.
7. Doerflinger, N. H., W. B. Macklin, and B. Popko. 2003. Inducible site-specific recombination in myelinating cells. Genesis 35:63-72.
8. Drescher, K. M., and S. M. Tracy. 2007. Injection of the sciatic nerve with TMEV: a new model for peripheral nerve demyelination. Virology 359:233-242.
9. Fan, J., K. N. Son, S. Y. Arslan, Z. Liang, and H. L. Lipton. 2009. Theiler's murine encephalomyelitis virus leader protein is the only nonstructural protein tested that induces apoptosis when transfected into mammalian cells. J. Virol. 83:6546-6553.
10. Gilden, D. H. 2005. Infectious causes of multiple sclerosis. Lancet Neurol. 4:195-202.
11. Hato, S. V., et al. 2007. The mengovirus leader protein blocks interferonalpha/ beta gene transcription and inhibits activation of interferon regulatory factor 3. Cell. Microbiol. 9:2921-2930.
12. Henderson, A. P., M. H. Barnett, J. D. Parratt, and J. W. Prineas. 2009. Multiple sclerosis: distribution of inflammatory cells in newly forming lesions. Ann. Neurol. 66:739-753.
13. Himeda, T., T. Okuwa, Y. Muraki, and Y. Ohara. 2010. Cytokine/chemokine profile in J774 macrophage cells persistently infected with DA strain of Theiler's murine encephalomyelitis virus (TMEV). J. Neurovirol. 16:219-229.
14. Hou, W., H. S. Kang, and B. S. Kim. 2009. Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection. J. Exp. Med. 206:313-328.
15. Kornek, B., et al. 2000. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am. J. Pathol. 157:267-276.
16. Leone, D. P., et al. 2003. Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cells. Mol. Cell. Neurosci. 22:430-440.
17. Lin, W., et al. 2007. The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage. J. Clin. Invest. 117:448-456.
18. Lipton, H. L., Z. Liang, S. Hertzler, and K. N. Son. 2007. A specific viral cause of multiple sclerosis: one virus, one disease. Ann. Neurol. 61:514-523.
19. Matthews, A. E., E. Lavi, S. R. Weiss, and Y. Paterson. 2002. Neither B cells nor T cells are required for CNS demyelination in mice persistently infected with MHV-A59. J. Neurovirol. 8:257-264.
20. Michiels, T., and R. P. Roos. 2010. Theiler's virus central nervous system infection, p. 411-428. In E. Ehrenfeld, E. Domingo, and R. P. Roos (ed.), The picornaviruses. ASM Press, Washington, DC.
21. Olson, J. K., and S. D. Miller. 2004. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 173:3916-3924.
22. Pohl, H. B. F., et al. 2011. Genetically induced adult oligodendrocyte cell death is associated with poor myelin clearance, reduced remyelination, and axonal damage. J. Neurosci. 31:1069-1080.
23. Porter, F. W., Y. A. Bochkov, A. J. Albee, C. Wiese, and A. C. Palmenberg. 2006. A picornavirus protein interacts with Ran-GTPase and disrupts nucleocytoplasmic transport. Proc. Natl. Acad. Sci. U. S. A. 103:12417-12422.
24. Richards, M. H., et al. 2011. Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS. J. Autoimmun. 36:142-154.
25. Rodriguez, M. 1985. Virus-induced demyelination in mice: "dying back" of oligodendrocytes. Mayo Clinic Proc. 60:433-438.
26. Rodriguez, M., J. L. Leibowitz, and P. W. Lampert. 1983. Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann. Neurol. 13:426-433.
27. Romanova, L. I., et al. 2009. Antiapoptotic activity of the cardiovirus leader protein, a viral "security" protein. J. Virol. 83:7273-7284.
28. Roos, R. P., et al. 1990. Infectious Theiler's virus cDNA clones: intratypic recombinants and viral polyprotein processing, p. 128-134. In M. A. Brinton and F. X. Heinz (ed.), New aspects of positive-strand RNA viruses. American Society for Microbiology, Washington, DC.
29. Roos, R. P., and R. Wollmann. 1984. DA strain of Theiler's murine encephalomyelitis virus induces demyelination in nude mice. Ann. Neurol. 15:494-499.
30. Rosenthal, A., R. S. Fujinami, and P. W. Lampert. 1986. Mechanism of Theiler's virus-induced demyelination in nude mice. Lab. Invest. 54:515-522.
31. Sathornsumetee, S., D. B. McGavern, D. R. Ure, and M. Rodriguez. 2000. Quantitative ultrastructural analysis of a single spinal cord demyelinated lesion predicts total lesion load, axonal loss, and neurological dysfunction in a murine model of multiple sclerosis. Am. J. Pathol. 157:1365-1376.
32. Scheper, G. C., M. S. van der Knaap, and C. G. Proud. 2007. Translation matters: protein synthesis defects in inherited disease. Nat. Rev. Genet. 8:711-723.
33. Schlitt, B. P., M. Felrice, M. L. Jelachich, and H. L. Lipton. 2003. Apoptotic cells, including macrophages, are prominent in Theiler's virus-induced inflammatory, demyelinating lesions. J. Virol. 77:4383-4388.
34. Stavrou, S., et al. 2010. Theiler's murine encephalomyelitis virus L* amino acid position 93 is important for virus persistence and virus-induced demyelination. J. Virol. 84:1348-1354.
35. Stavrou, S., Z. Feng, S. M. Lemon, and R. P. Roos. 2010. Different strains of Theiler's murine encephalomyelitis virus antagonize different sites in the type I interferon pathway. J. Virol. 84:9181-9189.
36. Stavrou, S., G. Ghadge, and R. P. Roos. 2011. Apoptotic and antiapoptotic activity of L protein of Theiler's murine encephalomyelitis virus. J. Virol. 85:7177-7185.
37. Takata, H., et al. 1998. L* protein of the DA strain of Theiler's murine encephalomyelitis virus is important for virus growth in a murine macrophage-like cell line. J. Virol. 72:4950-4955.
38. Traka, M., et al. 2010. A genetic mouse model of adult-onset, pervasive central nervous system demyelination with robust remyelination. Brain 133: 3017-3029.
39. Tsunoda, I., C. I. Kurtz, and R. S. Fujinami. 1997. Apoptosis in acute and chronic central nervous system disease induced by Theiler's murine encephalomyelitis virus. Virology 228:388-393.
40. van der Knaap, M. S., J. C. Pronk, and G. C. Scheper. 2006. Vanishing white matter disease. Lancet Neurol. 5:413-423.
41. van Pesch, V., O. van Eyll, and T. Michiels. 2001. The leader protein of Theiler's virus inhibits immediate-early alpha/beta interferon production. J. Virol. 75:7811-7817.
42. Vargas, M. E., and B. A. Barres. 2007. Why is Wallerian degeneration in the CNS so slow? Annu. Rev. Neurosci. 30:153-179.
43. Wu, G. F., A. A. Dandekar, L. Pewe, and S. Perlman. 2000. CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination. J. Immunol. 165:2278-2286.
44. Zuvich, R. L., et al. 2010. Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility. Hum. Genet. 127:525-535.